Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia.

Acciarri A, Masullo C, Bizzarro A, Valenza A, Quaranta D, Marra C, Tiziano FD, Brahe C, Seripa D, Matera MG, Fazio VM, Gainotti G, Daniele A.

Ann Neurol. 2006 Feb;59(2):436-7. No abstract available.

PMID:
16437577
2.

The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy.

Masullo C, Daniele A, Fazio VM, Seripa D, Gravina C, Filippini V, Grossi D, Fragassi N, Nichelli P, Leone M, Gainotti G.

Neurosci Lett. 2001 May 4;303(2):87-90. Erratum in: Neurosci Lett 2001 Jul 27;308(1):66.

PMID:
11311499
3.

Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese.

Wang B, Zhao H, Zhou L, Dai X, Wang D, Cao J, Niu W.

J Neurol Sci. 2009 Jan 15;276(1-2):118-22. doi: 10.1016/j.jns.2008.09.013. Epub 2008 Oct 11.

PMID:
18851860
4.

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.

PMID:
17689519
5.

Apolipoprotein E genotypes in primary progressive aphasia.

Mesulam MM, Johnson N, Grujic Z, Weintraub S.

Neurology. 1997 Jul;49(1):51-5.

PMID:
9222169
6.

The APOE gene locus in frontotemporal dementia and primary progressive aphasia.

Seripa D, Bizzarro A, Panza F, Acciarri A, Pellegrini F, Pilotto A, Masullo C.

Arch Neurol. 2011 May;68(5):622-8. doi: 10.1001/archneurol.2011.90.

PMID:
21555637
7.

APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women.

Daniele A, Matera MG, Seripa D, Acciarri A, Bizzarro A, Pilotto A, Masullo C.

Arch Neurol. 2009 Jul;66(7):910-2. doi: 10.1001/archneurol.2009.136. No abstract available.

PMID:
19597098
8.

Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.

Licastro F, Porcellini E, Caruso C, Lio D, Corder EH.

Neurobiol Aging. 2007 Nov;28(11):1637-43. Epub 2006 Aug 22.

PMID:
16930778
9.

Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD).

Baird PN, Richardson AJ, Robman LD, Dimitrov PN, Tikellis G, McCarty CA, Guymer RH.

Hum Mutat. 2006 Apr;27(4):337-42.

PMID:
16453339
10.

Distribution of APOE genotypes in a memory clinic cohort.

van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P.

Dement Geriatr Cogn Disord. 2008;25(5):433-8. doi: 10.1159/000124750. Epub 2008 Apr 10.

PMID:
18401171
11.

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study.

Anuurad E, Lu G, Rubin J, Pearson TA, Berglund L.

J Lipid Res. 2007 Mar;48(3):693-8. Epub 2006 Dec 15.

12.

[Influence of the APOE genotypes in some atherosclerotic risk factors].

Carmo Martins M, Lima Faleiro L, Rodrigues MO, Albergaria I, Fonseca A.

Acta Med Port. 2008 Sep-Oct;21(5):433-40. Epub 2009 Jan 16. Portuguese.

13.

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.

Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, Schmidt H, Schmidt R, Hillert J, Masterman T, Hogh P, Niino M, Kikuchi S, Maciel P, Santos M, Rio ME, Kwiecinski H, Zakrzewska-Pniewska B, Evangelou N, Palace J, Barcellos LF.

Neurology. 2006 May 9;66(9):1373-83.

PMID:
16682670
14.

Lack of association between apolipoprotein E polymorphism and vascular dementia in Koreans.

Kim KW, Youn JC, Han MK, Paik NJ, Lee TJ, Park JH, Lee SB, Choo IH, Lee DY, Jhoo JH, Woo JI.

J Geriatr Psychiatry Neurol. 2008 Mar;21(1):12-7. doi: 10.1177/0891988707311028.

PMID:
18287165
15.

APOE-related mortality: effect of dementia, cardiovascular disease and gender.

Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L.

Neurobiol Aging. 2009 Oct;30(10):1545-51. doi: 10.1016/j.neurobiolaging.2007.12.003. Epub 2008 Jan 30.

PMID:
18237822
16.

Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population.

Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Egashira T, Hattori H, Kita T.

J Atheroscler Thromb. 2007 Aug;14(4):167-71. Epub 2007 Aug 14.

17.

Association between ApoE epsilon4 and cognitive impairment after stroke.

Wagle J, Farner L, Flekkøy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrød B, Engedal K.

Dement Geriatr Cogn Disord. 2009;27(6):525-33. doi: 10.1159/000223230. Epub 2009 Jun 4.

PMID:
19494491
18.

Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.

Kamruecha W, Chansirikarnjana S, Nimkulrat E, Udommongkol C, Wongmek W, Thangnipon W.

Southeast Asian J Trop Med Public Health. 2006 Jul;37(4):793-7.

PMID:
17121308
19.

Apolipoprotein E gene polymorphism in the Mongolian population.

Svobodová H, Kucera F, Stulc T, Vrablík M, Amartuvshin B, Altannavch Ts, Ceska R.

Folia Biol (Praha). 2007;53(4):138-42.

20.

Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.

Volcik KA, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, Ballantyne CM, Boerwinkle E.

Am J Epidemiol. 2006 Aug 15;164(4):342-8. Epub 2006 Jun 7.

PMID:
16760224

Supplemental Content

Support Center